Preparation, Characterization, and Preliminary Imaging Study of [¹⁸⁸Re]Re-Ibandronate as a Novel Theranostic Radiopharmaceutical for Bone Metastasis

Figure 8

Pathology of mice at 4 weeks after injection of 37 MBq [¹⁸⁸Re]Re-IBA (high-dose group): (a) heart; (b) liver; (c) spleen; (d) lung; (e) stomach; (f) kidney; (g) brain; (h) small intestine; (i) muscle; (j) bone marrow. (a)–(i) HE × 200; (j) HE × 400.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)